IRIS
TINI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.911
EU - Europa 4.272
AS - Asia 2.954
SA - Sud America 577
AF - Africa 187
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.912
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.795
RU - Federazione Russa 1.075
CN - Cina 893
GB - Regno Unito 881
SG - Singapore 855
IT - Italia 626
IE - Irlanda 517
BR - Brasile 465
VN - Vietnam 425
HK - Hong Kong 256
DE - Germania 243
SE - Svezia 228
UA - Ucraina 209
FR - Francia 188
KR - Corea 143
FI - Finlandia 118
ZA - Sudafrica 110
IN - India 105
BD - Bangladesh 63
ES - Italia 57
CA - Canada 53
AR - Argentina 39
TR - Turchia 39
MX - Messico 35
NL - Olanda 29
IQ - Iraq 22
JP - Giappone 22
PL - Polonia 19
BE - Belgio 18
ID - Indonesia 17
PK - Pakistan 17
AT - Austria 16
UZ - Uzbekistan 16
EC - Ecuador 15
NG - Nigeria 15
CO - Colombia 14
IR - Iran 13
KE - Kenya 12
MA - Marocco 12
PY - Paraguay 11
CL - Cile 10
LT - Lituania 10
SA - Arabia Saudita 10
VE - Venezuela 10
TN - Tunisia 9
AU - Australia 8
ET - Etiopia 8
JM - Giamaica 8
IM - Isola di Man 7
JO - Giordania 7
DZ - Algeria 6
NP - Nepal 6
TH - Thailandia 6
UY - Uruguay 6
MY - Malesia 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
EG - Egitto 4
HN - Honduras 4
RO - Romania 4
BH - Bahrain 3
BO - Bolivia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
GA - Gabon 3
GR - Grecia 3
IL - Israele 3
PA - Panama 3
PE - Perù 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BW - Botswana 2
BY - Bielorussia 2
CR - Costa Rica 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
NO - Norvegia 2
OM - Oman 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GT - Guatemala 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
Totale 12.903
Salva come PNG Salva come JPEG
Città #
Southend 725
Dallas 550
Dublin 506
Singapore 482
Fairfield 371
Ashburn 365
Moscow 323
San Jose 323
Santa Clara 272
Chandler 247
Hong Kong 241
Beijing 227
Hefei 214
Wilmington 168
Woodbridge 168
Ann Arbor 166
Jacksonville 164
Seattle 147
Houston 144
Seoul 142
Ho Chi Minh City 139
Siena 131
New York 129
Cambridge 106
Johannesburg 102
Menlo Park 98
Hanoi 88
Los Angeles 88
Council Bluffs 83
Princeton 71
The Dalles 69
Milan 67
Munich 64
Rome 64
Florence 62
Lauterbourg 56
Helsinki 55
Nanjing 52
Dearborn 45
Buffalo 44
Fremont 43
Shanghai 35
Málaga 33
Orem 30
London 29
São Paulo 29
Boardman 27
Bengaluru 24
Izmir 24
Tianjin 24
Nuremberg 23
Dong Ket 22
San Diego 22
Redondo Beach 21
Tokyo 21
Chennai 20
Da Nang 20
San Mateo 20
Chicago 19
Frankfurt am Main 19
Brussels 18
Montreal 18
Phoenix 17
Shenyang 17
Turku 17
Brooklyn 16
Columbus 16
Guangzhou 16
Stockholm 16
Haiphong 15
Abuja 14
Mexico City 14
Palermo 14
Rio de Janeiro 14
Warsaw 14
Manchester 13
Mumbai 13
Atlanta 12
Lappeenranta 12
Nanchang 12
Tashkent 12
Toronto 12
Amsterdam 11
Belo Horizonte 11
Kunming 11
San Francisco 11
Turin 11
Brasília 10
Hebei 10
Jinan 10
Naples 10
Poplar 10
Barnet 9
Changsha 9
Dhaka 9
Falkenstein 9
Vienna 9
Zhengzhou 9
Baghdad 8
Biên Hòa 8
Totale 8.560
Salva come PNG Salva come JPEG
Nome #
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 369
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 321
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 302
Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence 302
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 297
Diffusion-weighted magnetic resonance diagnosis of local recurrences of prostate cancer after radical prostatectomy: preliminary evaluation on twenty-seven cases 283
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 280
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 276
Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells 271
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 258
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 256
Beta-catenin and Gli1 are prognostic markers in glioblastoma 249
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 236
Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and Temozolomide combined treatments 230
Autofagia nei gliomi HG: analisi ed interpretazione di dati clinici e biologici 224
Beta-Catenin and Gli-1 as prognostic markers in Glioblastoma Multiforme. 221
Diffusion-weighted MR volumetry for assessing the response of rectal cancer to combined radiation therapy with chemotherapy 218
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 218
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 214
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 213
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status 203
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 200
The prognostic role of Beclin 1 protein expression in high-grade gliomas 194
Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes 194
Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective? 191
Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer) 190
Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide 188
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 187
Challenges and Opportunities in Accessing Surgery for Glioblastoma in Low–Middle Income Countries: A Narrative Review 171
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 166
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 165
Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism? 162
Feasibility of clinical target volume reduction for glioblastoma treated with standard chemoradiation based on patterns of failure analysis 161
Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems 158
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 153
Epidermal Growth Factor Receptor Expression May Correlate with Survival Through Clinical and Radiological Features of Aggressiveness in Glioblastoma Treated with Radiochemotherapy 148
Correction to: Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery (Journal of Neuro-Oncology, (2024), 10.1007/s11060-024-04818-9) 145
Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas 142
null 139
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 138
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 136
In Regard to Kubicek et al. 133
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 132
null 130
null 126
Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues 125
Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery 122
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge 120
Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol 120
null 117
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 116
null 116
Comment on “Everolimus induces G1 cell cycle arrest through autophagy-mediated protein degradation of cyclin D1 in breast cancer cells” 114
Persistent hiccup after chemo-radiotherapy in nasopharyngeal cancer: an atypical side effect? 111
The role of delta radiomics in gastric cancer 110
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 108
Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma 105
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 102
Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer 100
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 100
null 99
Inflammatory markers and procalcitonin predict the outcome of metastatic non-small-cell-lung-cancer patients receiving PD-1/PD-L1 Immune-Checkpoint Blockade 95
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov 94
Watch the Mass, Save the Gland (Radiation Therapy Perhaps Later) 93
Assessing ChatGPT-4 as a clinical decision support tool in neuro-oncology radiotherapy: a prospective comparative study 91
The evolving role of reirradiation in the management of recurrent brain tumors 86
Letter to the Editor: Commentary on “Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma” 86
Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases 86
Delta-radiomics increases multicentre reproducibility: a phantom study 85
null 83
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 82
null 82
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 81
Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study 81
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 80
Stereotactic radiotherapy for brain oligometastases 79
How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies 77
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 75
Multimodality Imaging Assessment of Malignant Pleural Mesothelioma 75
Music therapy and radiation oncology: State of art and future directions 73
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 68
Tips and tricks of spinal cord biopsy: insights from a multicenter series of 61 patients 65
Role of the Appropriateness of the Pelvic Lymphadenectomy and Adjuvant Radiation Therapy in Early-Stage Poorly Differentiated Endometrial Carcinoma 64
Tumors of the optic nerve and its sheath 63
Cell Death Pathways, with Special Regard to Ionizing Radiation and Temozolomide 56
Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature? 54
Clinical, Pathological, and Molecular Prognostic Parameters in Glioblastoma Patients Undergoing Chemo- and Radiotherapy 49
Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas—prognostic significance in different biological sub-groups 43
Mathematical Modelling of Radiobiological Parameters 18
miRNA Manipulation in Modifying Radiation Sensitivity in Glioblastoma Models 18
Totale 13.157
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 0 0 76
2021/2022567 52 59 42 42 42 31 26 30 27 50 55 111
2022/2023874 47 74 130 113 79 155 23 71 80 44 27 31
2023/2024866 22 19 82 54 36 223 337 15 7 19 18 34
2024/20252.070 64 71 174 87 191 254 58 147 119 93 215 597
2025/20265.611 436 701 529 776 1.180 221 703 187 169 429 157 123
Totale 13.157